Adherium receives U.S. FDA 510(k) clearance for Teva’s ProAir® and Albuterol Sulphate inhaler users to remotely monitor physiological parametersMelbourne, Australia – 23 March 2023, Link Here : Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce that it has received U.S. Food and Drug […]
Received Outstanding Achievement in Research for EVOKE Clinical Trial Sustained Superiority of Evoke® Closed-Loop Pain Relief and Improvement in Quality-of-Life Scores at 36-months Artarmon, Australia – March 22, 2023 – Link here – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that the EVOKE 36-month […]
LA JOLLA, Calif., March 20, 2023 (GLOBE NEWSWIRE): News Link – CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC” – Cash and cash equivalents of approximately $34 million as of merger close expected to support operations into the second half of 2024 – Phase 2b results in acute pancreatitis for lead […]
ASX Release: 23 January 2023 Melbourne, Australia; Acrux Limited (ASX:ACR) Link Here: Acrux today announced that it has concluded an agreement with Gedeon Richter Plc., one of its manufacturing and distribution partners, for Gedeon Richter to buy out the future royalties of Lenzetto® for contracted territories for EUR4.10 million, which at current rates of exchange […]
Melbourne, Australia – Link Here: Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce receiving Australian Therapeutic Goods Administration (TGA) approval to commercially distribute its new, next generation Hailie® sensors with physiological parameters. These latest additions to the Hailie sensor product family connect patients […]
11 EXECUTIVES, 55 COMPANIES AND 91 PRODUCTS WIN 2023 BIG INNOVATION AWARD BUSINESS INTELLIGENCE GROUP ANNOUNCES THE WINNERS OF THE 2023 BIG INNOVATION AWARDS Philadelphia, PA— Link Here —Today, the Business Intelligence Group named 11 executives, 55 companies, and 91 products as leaders and winners of the 2023 BIG Innovation Awards. This annual business awards […]
Melbourne, Australia – 28 November 2022: (Link Here) Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that is has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market application, connecting GlaxoSmithKline’s (GSK) Ventolin®, Advair®, and Flovent® pressurised metered dose inhaler (pMDI) users with […]
November 21, 2022 18:52 ET | Source: Graybug Vision, Inc.; CalciMedica Inc. Link here Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates for life-threatening inflammatory diseases Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into […]
Melbourne, Australia – 21 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce the appointment of Mr Daniel Kaplon as Chief Financial Officer, effective 10 October 2022. Mr Rick Legleiter, Adherium Chief Executive Officer, commented, “we are very pleased to […]
Melbourne, Australia – 20 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce a two-part clinical study at Washington University School of Medicine in St. Louis in the United States to monitor the adherence of Asthma patients using Adherium’s US […]